Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-02 Sale | 2024-12-04 5:35 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 15,000 | $55.1 | $826,565 | 267,162 (Indirect Direct) | View |
| 2024-11-11 Sale | 2024-11-13 5:35 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 30,000 | $55.62 | $1,668,678 | 282,162 (Indirect Direct) | View |
| 2024-10-14 Sale | 2024-10-15 6:00 pm | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 1,089 | $46.28 | $50,399 | 66,824 (Direct) | View |
| 2024-10-14 Sale | 2024-10-15 6:00 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 4,293 | $46.28 | $198,680 | 328,829 (Indirect Direct) | View |
| 2024-06-21 Sale | 2024-06-24 5:35 pm | CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer | 3,366 | $56.09 | $188,799 | 13,833 (Indirect Direct) | View |
| 2024-04-15 Sale | 2024-04-17 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 19,582 | $59.91 | $1,173,232 | 408,122 (Indirect Direct) | View |
| 2024-03-15 Sale | 2024-03-18 5:45 pm | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 3,524 | $72.69 | $256,160 | 36,476 (Direct) | View |
| 2024-03-15 Sale | 2024-03-18 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $72.48 | $1,449,628 | 427,704 (Indirect Direct) | View |
| 2024-03-11 Sale | 2024-03-12 5:45 pm | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 3,947 | $77.15 | $304,515 | 79,924 (Direct) | View |
| 2024-03-11 Sale | 2024-03-12 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 14,385 | $77.04 | $1,108,263 | 474,872 (Indirect Direct) | View |
| 2024-02-20 Sale | 2024-02-21 5:45 pm | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 1,913 | $79.67 | $152,409 | 65,021 (Direct) | View |
| 2024-02-20 Sale | 2024-02-21 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 6,370 | $79.67 | $507,498 | 420,757 (Indirect Direct) | View |
| 2024-02-15 Sale | 2024-02-16 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $80.36 | $1,607,177 | 426,959 (Indirect Direct) | View |
| 2024-01-29 Sale | 2024-01-31 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 50,000 | $60.51 | $3,025,573 | 487,377 (Indirect Direct) | View |
| 2024-01-16 Sale | 2024-01-18 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $62.5 | $1,250,058 | 446,959 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-16 Option Award | 2024-10-18 5:35 pm | N/A 2034-10-16 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 48,333 | $0 | 48,333 (Direct) | View |
| 2024-10-16 Option Award | 2024-10-18 5:35 pm | N/A 2034-10-16 | CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer | 18,333 | $0 | 18,333 (Direct) | View |
| 2024-10-16 Option Award | 2024-10-18 5:35 pm | N/A 2034-10-16 | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 18,333 | $0 | 18,333 (Direct) | View |
| 2024-10-16 Option Award | 2024-10-18 5:35 pm | N/A 2034-10-16 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 455,000 | $0 | 455,000 (Direct) | View |
| 2024-10-16 Option Award | 2024-10-18 5:35 pm | N/A 2034-10-16 | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 33,333 | $0 | 33,333 (Direct) | View |
| 2024-10-13 Exercise | 2024-10-15 6:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 2,113 | $0 | 66,824 (Direct) | View |
| 2024-10-13 Exercise | 2024-10-15 6:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 8,333 | $0 | 328,829 (Direct) | View |
| 2024-08-08 Gift | 2024-08-12 6:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 100,000 | $0 | 308,122 (Direct) | View |
| 2024-06-20 Exercise | 2024-06-24 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer | 7,000 | $0 | 13,833 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-31 4:50 pm | N/A 2034-05-30 | CRISPR Therapeutics AG | CRSP | George Simeon Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-31 4:50 pm | N/A 2034-05-30 | CRISPR Therapeutics AG | CRSP | Behbahani Ali Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-31 4:15 pm | N/A 2034-05-30 | CRISPR Therapeutics AG | CRSP | Mahatme Sandesh Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-31 4:15 pm | N/A 2034-05-30 | CRISPR Therapeutics AG | CRSP | Fardis Maria Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-31 4:15 pm | N/A 2034-05-30 | CRISPR Therapeutics AG | CRSP | Greene John Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-31 4:15 pm | N/A 2034-05-30 | CRISPR Therapeutics AG | CRSP | Rommel Christian Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-31 4:15 pm | N/A 2034-05-30 | CRISPR Therapeutics AG | CRSP | High Katherine A Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-31 4:15 pm | N/A 2034-05-30 | CRISPR Therapeutics AG | CRSP | Treco Douglas A Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-31 4:15 pm | N/A 2034-05-30 | CRISPR Therapeutics AG | CRSP | Fleming Harold Edward Director | 13,000 | $0 | 13,000 (Direct) | View |
Ownership | 2024-05-30 4:27 pm | N/A 2033-10-16 | CRISPR Therapeutics AG | CRSP | Mahatme Sandesh Director | 0 | $0 | 26,000 (Direct) | View |
| 2024-05-28 Option Award | 2024-05-29 4:15 pm | N/A 2034-05-28 | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:15 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2024-05-23 4:25 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer | 0 | $0 | 148,752 (Direct) | View |
| 2024-04-15 Exercise | 2024-04-17 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 19,582 | $19.12 | 408,122 (Direct) | View |
| 2024-04-15 Exercise | 2024-04-17 5:45 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 19,582 | $0 | 408,122 (Direct) | View |
| 2024-03-20 Option Award | 2024-03-22 5:45 pm | N/A 2034-03-20 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 58,333 | $0 | 58,333 (Direct) | View |
| 2024-03-20 Option Award | 2024-03-22 5:45 pm | N/A 2034-03-20 | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 61,168 | $0 | 61,168 (Direct) | View |
| 2024-03-20 Option Award | 2024-03-22 5:45 pm | N/A 2034-03-20 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 183,750 | $0 | 183,750 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-18 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 10,000 | $0 | 36,476 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-18 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $19.12 | 427,704 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-18 5:45 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $0 | 427,704 (Direct) | View |
| 2024-03-10 Exercise | 2024-03-12 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 7,750 | $0 | 79,924 (Direct) | View |
| 2024-03-10 Exercise | 2024-03-12 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 28,250 | $0 | 474,872 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-27 6:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | George Simeon Director | 1,048,951 | $71.5 | 769,196 (Indirect) | View |
| 2024-02-18 Exercise | 2024-02-21 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 3,825 | $0 | 65,021 (Direct) | View |
| 2024-02-18 Exercise | 2024-02-21 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 13,250 | $0 | 420,757 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $19.12 | 426,959 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 5:45 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $0 | 426,959 (Direct) | View |
| 2024-01-29 Exercise | 2024-01-31 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 50,000 | $19.12 | 487,377 (Direct) | View |
| 2024-01-29 Exercise | 2024-01-31 5:45 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 50,000 | $0 | 487,377 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $19.12 | 446,959 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 5:45 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $0 | 446,959 (Direct) | View |